000 02264cam  2200349zi 4500
0019.921571
003CaOODSP
00520230515120842
006m     o  d f      
007cr |n|||||||||
008230406e20211110onc     ob   f000 0 eng d
020 |a9780660406923
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH139-30/2021E-PDF
24500|aGuide to distributing drugs intended for the Canadian market for consumption or use outside Canada (GUI-0145).
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cNovember 10, 2021.
264 4|c©2021
300 |a1 online resource (14 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Guide sur la distribution des médicaments destinés au marché canadien pour consommation ou usage à l’extérieur du Canada (GUI-0145).
504 |aIncludes bibliographical references (pages 13-14).
520 |a"This guidance document sets out Health Canada’s interpretation of the requirements in sections C.01.014.8, C.10.004 and C.01.014.13 to C.01.014.14 of the FDR. These sections prohibit the holder of a DEL from distributing drugs intended for the Canadian market for consumption or use outside Canada unless the licensee has reasonable grounds to believe that doing so would not cause or worsen a drug shortage. The sections were implemented to safeguard the Canadian drug supply and help ensure that the people of Canada have continuous access to the drugs they need to maintain their health"--Purpose, page 5.
650 0|aDrugs|xLaw and legislation|zCanada.
650 0|aPharmaceutical policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tGuide sur la distribution des médicaments destinés au marché canadien pour consommation ou usage à l’extérieur du Canada (GUI-0145).|w(CaOODSP)9.921572
85640|qPDF|s731 KB|uhttps://publications.gc.ca/collections/collection_2023/sc-hc/H139-30-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/drugs-health-products/guide-distributing-canadian-market-consumption-outside-canada.html